Demand for Intuitive Surgical's da Vinci surgical robot is growing faster than the company's sales of new robots.
Intuitive Surgical (NASDAQ: ISRG) has rewarded long-term investors by climbing nearly 200% over the past five years. This is thanks to the company's leadership in a hot growth area: robotic surgery.
Citi analyst Joanne Wuensch reiterated a Buy rating on Intuitive Surgical (ISRG – Research Report) yesterday and set a price target of $711.00. The company’s shares closed yesterday at $608.66.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback